For the quarter ending 2025-03-31.
| Income Statement | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Research and development | 28,808 | -124,668.5* | 4,463 | 593,784 |
| General and administrative | 690,852 | 562,961* | 823,250 | 700,784 |
| Depreciation and amortization | - | 1,428* | - | - |
| Total operating expenses | - | 439,720.5 | - | - |
| Loss from operations | -719,660 | -439,720.5* | -827,713 | -1,294,568 |
| Interest income | 369 | 11,326* | 3,173 | 11,581 |
| Sale of royalty and milestone rights, net of transaction costs | - | 2,000,000* | - | - |
| Net income (gain) | -719,291 | 1,571,605.5 | -824,540 | -1,282,987 |
| Net income (gain) attributable to common stockholders | - | 1,571,605.5 | -824,540 | -1,282,987 |
| Basic EPS | -1.45 | 3.174 | -1.67 | -2.59 |
| Diluted EPS | -1.45 | 3.174 | -1.67 | -2.59 |
| Basic Average Shares | 495,092 | 495,092 | 495,092 | 495,092 |
| Diluted Average Shares | 495,092 | 495,092 | 495,092 | 495,092 |
LadRx Corp (LADX)
LadRx Corp (LADX)